Annotation plays a pivotal role in the development of personalized medicine by enabling the identification of specific genetic alterations in individual patients. This information can be used to tailor treatments based on the unique genetic profile of a patient's tumor. For instance, the annotation of EGFR mutations in lung cancer patients has led to the use of targeted therapies like tyrosine kinase inhibitors.
